Sarah K. Johnson, Ph.D.
Research Assistant Professor, Department of Pathology
Ph.D., Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR Post-doctoral Fellowship, Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC
Selected Publications:
Wei Xiong, Xiaosong Wu, Sarah Starnes, Sarah K. Johnson1, Jeff Haessler, Siqing Wang, Lijuan Chen, Bart Barlogie, John D. Shaughnessy, Jr, and Fenghuang Zhan. An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood, 15 November 2008, Vol. 112, No. 10, pp. 4235-4246
Johnson Sarah K., Vishnu P. Ramani, Laura W. Lamps and Randy S. Haun. Kallikrein
7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer, 2007;
109:1811-1820.
Johnson Sarah K., Richard Dennis, Laura W. Lamps and Randy S. Haun. Differential Expression of Insulin-like Growth Factor Binding Protein 5 in Pancreatic Adenocarcinomas: Identification Using DNA Microarray. Mol Carcinog 2006; 45: 814–827.
Sarah K Johnson and Randy S Haun. The Gamma-Aminobutyric Acid A Receptor π Subunit Is Overexpressed in Pancreatic Adenocarcinomas. J Pancreas (Online) 2005; 6(2):6001-6007.
Ray A. Lebeda, Sarah K. Johnson, Malcolm I. Stewart, and Randy S. Haun. Sequence, genomic organization, and expression of the human ADP-ribosylation factor 6 (ARF6) gene: a class III ARF. DNA and Cell Biology, 22 (11), 737-741, 2003.
Having problems
with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for
Research and Therapy, University of Arkansas for Medical Sciences Terms and Conditions of Use
The information on the Myeloma Institute web site
is not intended as a substitute for professional medical attention. The
information is intended only as an aid in understanding current medical
knowledge. A physician should always be consulted for any health concern or
medical condition. The Myeloma Institute web site provides links to other
organizations as a service to our readers. The Myeloma Institute is not
responsible for the information provided on other web sites.